Hugh Griffith

Person

Edinburgh, GB

People

Patents Grantslast 30 patents

Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 12,054,510
- Issue date Aug 6, 2024
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of phosphate derivatives
- Patent number 12,054,511
- Issue date Aug 6, 2024
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of phosphoramidate derivatives of nucleoside drugs
- Patent number 11,786,544
- Issue date Oct 17, 2023
- NuCana plc
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 11,707,477
- Issue date Jul 25, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gemcitabine prodrugs
- Patent number 11,629,164
- Issue date Apr 18, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of diphosphate phosphoramidate of nucleosides as anticancer c...
- Patent number 11,560,400
- Issue date Jan 24, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of phosphate derivatives
- Patent number 11,414,452
- Issue date Aug 16, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cancer treatments
- Patent number 11,400,107
- Issue date Aug 2, 2022
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of gemcitabine
- Patent number 11,377,467
- Issue date Jul 5, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 11,352,387
- Issue date Jun 7, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 11,040,051
- Issue date Jun 22, 2021
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate nucleoside derivatives as anticancer agents
- Patent number 10,906,929
- Issue date Feb 2, 2021
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 10,786,523
- Issue date Sep 29, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of separating gemcitabine-phosphate diastereoisomers
- Patent number 10,669,300
- Issue date Jun 2, 2020
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gemcitabine prodrugs
- Patent number 10,662,213
- Issue date May 26, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for cancer
- Patent number 10,660,912
- Issue date May 26, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 10,570,168
- Issue date Feb 25, 2020
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 10,117,888
- Issue date Nov 6, 2018
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT REGIMENS
- Publication number 20240293439
- Publication date Sep 5, 2024
- NUCANA PLC
- Hugh Griffith
- G01 - MEASURING TESTING
Information Patent Application
FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
- Publication number 20240082287
- Publication date Mar 14, 2024
- NUCANA PLC
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS
- Publication number 20230226092
- Publication date Jul 20, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENTS
- Publication number 20230218655
- Publication date Jul 13, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...
- Publication number 20230192750
- Publication date Jun 22, 2023
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY
- Publication number 20230149436
- Publication date May 18, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF PHOSPHATE DERIVATIVES
- Publication number 20220402962
- Publication date Dec 22, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20220323475
- Publication date Oct 13, 2022
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...
- Publication number 20220306675
- Publication date Sep 29, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATION COMPRISING A GEMCITABINE-PRODRUG
- Publication number 20220031727
- Publication date Feb 3, 2022
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
- Publication number 20220031728
- Publication date Feb 3, 2022
- NUCANA PLC
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER...
- Publication number 20220024963
- Publication date Jan 27, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF GEMCITABINE
- Publication number 20210188893
- Publication date Jun 24, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...
- Publication number 20210171566
- Publication date Jun 10, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
- Publication number 20210130387
- Publication date May 6, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS
- Publication number 20210100825
- Publication date Apr 8, 2021
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATION COMPRISING A GEMCITABINE-PRODRUG
- Publication number 20200397810
- Publication date Dec 24, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Regimens
- Publication number 20200345755
- Publication date Nov 5, 2020
- NUCANA PLC
- Hugh Griffith
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20200268783
- Publication date Aug 27, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GEMCITABINE PRODRUGS
- Publication number 20200262861
- Publication date Aug 20, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy
- Publication number 20200197430
- Publication date Jun 25, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...
- Publication number 20200181189
- Publication date Jun 11, 2020
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF PHOSPHATE DERIVATIVES
- Publication number 20200181186
- Publication date Jun 11, 2020
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY
- Publication number 20190381084
- Publication date Dec 19, 2019
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
- Publication number 20190375779
- Publication date Dec 12, 2019
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
- Publication number 20190375778
- Publication date Dec 12, 2019
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENTS
- Publication number 20190374564
- Publication date Dec 12, 2019
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATION COMPRISING A GEMCITABINE-PRODRUG
- Publication number 20190022118
- Publication date Jan 24, 2019
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY
- Publication number 20190022117
- Publication date Jan 24, 2019
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
- Publication number 20180369266
- Publication date Dec 27, 2018
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hugh Griffith

Person

Patents Grantslast 30 patents

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Synthesis of phosphate derivatives

Formulations of phosphoramidate derivatives of nucleoside drugs

Formulation comprising a gemcitabine-prodrug

Gemcitabine prodrugs

Salts of diphosphate phosphoramidate of nucleosides as anticancer c...

Synthesis of phosphate derivatives

Cancer treatments

Crystalline form of gemcitabine

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Formulation comprising a gemcitabine-prodrug

Phosphoramidate nucleoside derivatives as anticancer agents

Formulation comprising a gemcitabine-prodrug

Methods of separating gemcitabine-phosphate diastereoisomers

Gemcitabine prodrugs

Combination therapy for cancer

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Formulation comprising a gemcitabine-prodrug

Patents Applicationslast 30 patents

TREATMENT REGIMENS

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS

CANCER TREATMENTS

SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...

COMBINATION THERAPY

SYNTHESIS OF PHOSPHATE DERIVATIVES

COMBINATION THERAPY FOR CANCER

2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...

FORMULATION COMPRISING A GEMCITABINE-PRODRUG

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER...

CRYSTALLINE FORM OF GEMCITABINE

SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...

PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS

CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS

FORMULATION COMPRISING A GEMCITABINE-PRODRUG

Treatment Regimens

COMBINATION THERAPY FOR CANCER

GEMCITABINE PRODRUGS

Combination Therapy

2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...

SYNTHESIS OF PHOSPHATE DERIVATIVES

COMBINATION THERAPY

PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS

ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

CANCER TREATMENTS

FORMULATION COMPRISING A GEMCITABINE-PRODRUG

COMBINATION THERAPY

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS